Gennaro D'Urso: PharmaDAO - The future of Medicine
DAO Camp 2022
Website: https://daocamp.org
Youtube: https://www.youtube.com/channel/UCeHtPZ_ZLZ-nHFMUCXY81RQ
FB: https://www.facebook.com/DAO-Camp-102442798988862/
2. Founded in 2015
Generating the GeneScape™ Proprietary Database
Gene Response Matrix and
Modular Biology
Dr. Gennaro D’Urso Dr. Leland Hartwell Dr. Corey Nislow Dr. Guri Giaever
Drug Response Matrix and
Chemogenomic Profiling
The GN STORY
7. Discovery Case Study
One Compound was
Tested in Vivo and
Showed Decrease of
Viral PCR Signal
Identified a
Handful of
Compounds with
Matching QR-
DRMs
Two of these
Compounds
Subsequently Showed
nM COVID-19 Antiviral
Activity in Vitro
Value
1 2 3
8. Early Discovery/ Pre-Clinical Phase 1 Phase 2 Phase 3 FDA
5-7 Years 2 Years 2 Years 2 Years 1.5 Years
89.5 % Failure rate 55.5% Failure rate 80.4% Failure rate 68.8% Failure rate 28.7% Failure rate
Conventional Path (New Drug)
AI Chemistry Phase 1 EUA Phase 2 - 3
2 Years 2 Years 1 Years 1 Years
Accelerated Path (Start with Validated Target)
Phase 2 - 3
< 2 years (EUA)
GeneScape™
Discovery Options